Lung Cancer Archives - Oncology Nurse Advisor Wed, 28 Feb 2024 14:06:29 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png Lung Cancer Archives - Oncology Nurse Advisor 32 32 Perioperative Tislelizumab Improves Outcomes in NSCLC https://www.oncologynurseadvisor.com/home/cancer-types/lung-cancer/perioperative-tislelizumab-improves-outcomes-in-nsclc/ Wed, 28 Feb 2024 13:45:00 +0000 https://www.oncologynurseadvisor.com/?p=116834 Tepmetko Gets Traditional Approval for MET Exon 14-Skipping NSCLC https://www.oncologynurseadvisor.com/home/cancer-types/lung-cancer/tepmetko-gets-traditional-approval-for-met-exon-14-skipping-nsclc/ Tue, 27 Feb 2024 14:15:00 +0000 https://www.oncologynurseadvisor.com/?p=116788 Pegargiminase Confers Survival Benefit in Nonepithelioid Pleural Mesothelioma https://www.oncologynurseadvisor.com/home/cancer-types/lung-cancer/pegargiminase-survival-benefit-nonepithelioid-pleural-mesothelioma/ Fri, 23 Feb 2024 14:10:00 +0000 https://www.oncologynurseadvisor.com/?p=116803 Perioperative Nivolumab-Based Regimen Under Review for Resectable NSCLC https://www.oncologynurseadvisor.com/home/cancer-types/lung-cancer/perioperative-nivolumab-based-regimen-under-review-for-resectable-nsclc/ Tue, 20 Feb 2024 14:15:00 +0000 https://www.oncologynurseadvisor.com/?p=116578 Prediagnosis Liquid Biopsy and Genetic Profiling Uptake Low in Advanced NSCLC https://www.oncologynurseadvisor.com/home/cancer-types/lung-cancer/prediagnosis-liquid-biopsy-genetic-profiling-uptake-advanced-cancer-treatment/ Fri, 16 Feb 2024 14:20:00 +0000 https://www.oncologynurseadvisor.com/?p=116772 Pembrolizumab Improves Event-Free Survival in Early NSCLC https://www.oncologynurseadvisor.com/home/cancer-types/lung-cancer/pembrolizumab-improves-event-free-survival-in-early-nsclc/ Fri, 16 Feb 2024 14:00:00 +0000 https://www.oncologynurseadvisor.com/?p=116710 Perioperative Nivolumab Improves EFS in NSCLC https://www.oncologynurseadvisor.com/home/cancer-types/lung-cancer/perioperative-nivolumab-improves-efs-in-nsclc-2/ Tue, 13 Feb 2024 14:15:00 +0000 https://www.oncologynurseadvisor.com/?p=113595 US Lung Cancer Incidence and Mortality on the Decline, Disparities Remain https://www.oncologynurseadvisor.com/home/cancer-types/lung-cancer/us-lung-cancer-incidence-mortality-decline-disparities-remain/ Fri, 09 Feb 2024 15:30:00 +0000 https://www.oncologynurseadvisor.com/?p=116574 First-Line Serplulimab Prolongs Survival in Advanced NSCLC https://www.oncologynurseadvisor.com/home/cancer-types/lung-cancer/first-line-serplulimab-prolongs-survival-in-advanced-nsclc/ Thu, 18 Jan 2024 15:30:00 +0000 https://www.oncologynurseadvisor.com/?p=116023 Moderate-to-Vigorous Exercise Can Delay Mortality in Inoperable Lung Cancer https://www.oncologynurseadvisor.com/home/cancer-types/lung-cancer/moderate-to-vigorous-exercise-can-delay-mortality-in-inoperable-lung-cancer/ Tue, 16 Jan 2024 15:00:00 +0000 https://www.oncologynurseadvisor.com/?p=115899